Literature DB >> 8571168

Immunopathological mechanisms in respiratory syncytial virus disease.

P J Openshaw1.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 8571168     DOI: 10.1007/bf00196165

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  68 in total

1.  Identification of a tenth mRNA of respiratory syncytial virus and assignment of polypeptides to the 10 viral genes.

Authors:  P L Collins; Y T Huang; G W Wertz
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

Review 2.  Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.

Authors:  K McIntosh; J M Fishaut
Journal:  Prog Med Virol       Date:  1980

3.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

4.  Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.

Authors:  B S Graham; G S Henderson; Y W Tang; X Lu; K M Neuzil; D G Colley
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

5.  Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children.

Authors:  J C King; A R Burke; J D Clemens; P Nair; J J Farley; P E Vink; S R Batlas; M Rao; J P Johnson
Journal:  Pediatr Infect Dis J       Date:  1993-09       Impact factor: 2.129

6.  Pulmonary epithelial T cells induced by viral infection express T cell receptors alpha/beta.

Authors:  P J Openshaw
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

7.  Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice.

Authors:  D N Ernst; M V Hobbs; B E Torbett; A L Glasebrook; M A Rehse; K Bottomly; K Hayakawa; R R Hardy; W O Weigle
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

8.  Respiratory syncytial viral infection in children with compromised immune function.

Authors:  C B Hall; K R Powell; N E MacDonald; C L Gala; M E Menegus; S C Suffin; H J Cohen
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

9.  Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

Authors:  C R Bangham; P J Openshaw; L A Ball; A M King; G W Wertz; B A Askonas
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

10.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  26 in total

Review 1.  Early life origins of asthma.

Authors:  J E Gern; R F Lemanske; W W Busse
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Infections prevent the development of asthma--true, false or both?

Authors:  P J Openshaw; G Walzl
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

3.  SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS.

Authors:  Roddy O'Donnell; Robert C Tasker; Michael F E Roe
Journal:  BMJ       Date:  2003-09-13

4.  Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.

Authors:  Ruihong Zeng; Huixian Zhang; Yan Hai; Yuxiu Cui; Lin Wei; Na Li; Jianxun Liu; Caixia Li; Ying Liu
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

5.  Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors:  Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.

Authors:  M Q Zhao; M H Stoler; A N Liu; B Wei; C Soguero; Y S Hahn; R I Enelow
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

7.  Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus.

Authors:  J B M van Woensel; W M C van Aalderen; W de Weerd; N J G Jansen; J P J van Gestel; D G Markhorst; A J van Vught; A P Bos; J L L Kimpen
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

8.  Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line.

Authors:  Yuh-Chin T Huang; Zhuowei Li; Xhevahire Hyseni; Michael Schmitt; Robert B Devlin; Edward D Karoly; Joleen M Soukup
Journal:  Genomic Med       Date:  2009-05-15

Review 9.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

Review 10.  The role of respiratory virus infections in childhood asthma inception.

Authors:  Daniel J Jackson; Robert F Lemanske
Journal:  Immunol Allergy Clin North Am       Date:  2010-09-22       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.